Title : In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.

Pub. Date : 2008 Aug

PMID : 18787741






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae. Tigecycline CTX-M-15 Klebsiella pneumoniae
2 In this study, we evaluated the in vitro antimicrobial activity of tigecycline against ESBL-producing Enterobacteriaceae, including Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae. Tigecycline CTX-M-15 Klebsiella pneumoniae
3 The in vitro activity of tigecycline against these ESBL producers was tested by use of Etest strips. Tigecycline CTX-M-15 Klebsiella pneumoniae
4 CONCLUSIONS: Tigecycline, a new semisynthetic glycylcycline, may be considered an alternative drug of choice for patients infected with ESBL-producing bacteria. Tigecycline CTX-M-15 Klebsiella pneumoniae